Objective validity of patient-reported symptoms in aspirin-exacerbated respiratory disease patients.

Patel, Pooja P; Cui, Jing; Cahill, Katherine N; Laidlaw, Tanya M

Patel, Pooja P; Cui, Jing; Cahill, Katherine N; Laidlaw, Tanya M.

Afiliación

Patel PP; Department of Medicine, Beth Israel Deaconess Hospital, Boston, Massachusetts, USA.
Cui J; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Cahill KN; Division of Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Laidlaw TM; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Clin Exp Allergy ; 52(2): 348-351, 2022 02.

Article en En | MEDLINE | ID: mdl-34820927

Asunto(s)

Asma Inducida por Aspirina; Antiinflamatorios no Esteroideos; Aspirina/efectos adversos; Asma Inducida por Aspirina/diagnóstico; Humanos; Medición de Resultados Informados por el Paciente

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma Inducida por Aspirina Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Clin Exp Allergy Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google